MDxHealth SelectMDx Liquid Biopsy Test
Mar 17, 2016
MDxHealth has launched its SelectMDx urine-based test for prostate cancer. SelectMDx for prostate cancer is a proprietary urine-based, molecular diagnostic test that offers a non-invasive method to identify patients at low risk for prostate cancer, the company said. The test will be commercially available in the US as a laboratory developed test.